+

WO2004038003A3 - Polypeptides humains codes par des polynucleotides et methodes d'utilisation - Google Patents

Polypeptides humains codes par des polynucleotides et methodes d'utilisation Download PDF

Info

Publication number
WO2004038003A3
WO2004038003A3 PCT/US2003/033947 US0333947W WO2004038003A3 WO 2004038003 A3 WO2004038003 A3 WO 2004038003A3 US 0333947 W US0333947 W US 0333947W WO 2004038003 A3 WO2004038003 A3 WO 2004038003A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
compositions
polypeptides encoded
Prior art date
Application number
PCT/US2003/033947
Other languages
English (en)
Other versions
WO2004038003A2 (fr
Inventor
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Srinivas Kothakota
Haishan Lin
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Changjiang Zeng
Original Assignee
Five Prime Therapeutics Inc
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Srinivas Kothakota
Haishan Lin
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Changjiang Zeng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Lewis T Williams, Keting Chu, Ernestine Lee, Kevin Hestir, Pierre Alvaro Beaurang, Dirk Behrens, Robert Forgan Halenbeck, Srinivas Kothakota, Haishan Lin, Thomas Linnemann, Kristen Pierce, Yan Wang, Justin G P Wong, Ge Wu, Hongbing Zhang, Changjiang Zeng filed Critical Five Prime Therapeutics Inc
Priority to AU2003298606A priority Critical patent/AU2003298606A1/en
Publication of WO2004038003A2 publication Critical patent/WO2004038003A2/fr
Publication of WO2004038003A3 publication Critical patent/WO2004038003A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides, des polypeptides apparentés, des compositions d'acides nucléiques et de polypeptides apparentées ainsi que des modulateurs apparentés, tels que des anticorps et des modulateurs de petites molécules. Cette invention concerne également des méthodes de production et d'utilisation de ces polynucléotides, polypeptides, compositions apparentées et modulateurs. Ces méthodes sont destinées à des applications diagnostiques, prophylactiques et thérapeutiques. Lesdites compositions et méthodes sont utiles dans le traitement de troubles de prolifération cellulaire, tels que les cancers, ainsi que de troubles inflammatoires, immunitaires, bactériens et viraux.
PCT/US2003/033947 2002-10-25 2003-10-24 Polypeptides humains codes par des polynucleotides et methodes d'utilisation WO2004038003A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003298606A AU2003298606A1 (en) 2002-10-25 2003-10-24 Human polypeptides encoded by polynucleotides and methods of their use

Applications Claiming Priority (126)

Application Number Priority Date Filing Date Title
US42155202P 2002-10-25 2002-10-25
US42161402P 2002-10-25 2002-10-25
US42106102P 2002-10-25 2002-10-25
US42108002P 2002-10-25 2002-10-25
US60/421,552 2002-10-25
US60/421,614 2002-10-25
US60/421,080 2002-10-25
US60/421,061 2002-10-25
US42217702P 2002-10-30 2002-10-30
US42217802P 2002-10-30 2002-10-30
US60/422,178 2002-10-30
US60/422,177 2002-10-30
US42639402P 2002-11-15 2002-11-15
US42691602P 2002-11-15 2002-11-15
US42635502P 2002-11-15 2002-11-15
US42643002P 2002-11-15 2002-11-15
US42638402P 2002-11-15 2002-11-15
US60/426,384 2002-11-15
US60/426,916 2002-11-15
US60/426,430 2002-11-15
US60/426,355 2002-11-15
US60/426,394 2002-11-15
US42932602P 2002-11-27 2002-11-27
US42922402P 2002-11-27 2002-11-27
US42927502P 2002-11-27 2002-11-27
US42965102P 2002-11-27 2002-11-27
US42930202P 2002-11-27 2002-11-27
US60/429,275 2002-11-27
US60/429,302 2002-11-27
US60/429,224 2002-11-27
US60/429,651 2002-11-27
US60/429,326 2002-11-27
US43064502P 2002-12-04 2002-12-04
US43066802P 2002-12-04 2002-12-04
US43068402P 2002-12-04 2002-12-04
US43065102P 2002-12-04 2002-12-04
US43065702P 2002-12-04 2002-12-04
US43066302P 2002-12-04 2002-12-04
US60/430,657 2002-12-04
US60/430,645 2002-12-04
US60/430,651 2002-12-04
US60/430,684 2002-12-04
US60/430,663 2002-12-04
US60/430,668 2002-12-04
US43093702P 2002-12-05 2002-12-05
US43145802P 2002-12-05 2002-12-05
US43096502P 2002-12-05 2002-12-05
US60/431,458 2002-12-05
US60/430,965 2002-12-05
US60/430,937 2002-12-05
US43325102P 2002-12-12 2002-12-12
US43350002P 2002-12-12 2002-12-12
US60/433,251 2002-12-12
US60/433,500 2002-12-12
US43331602P 2002-12-13 2002-12-13
US43331802P 2002-12-13 2002-12-13
US60/433,318 2002-12-13
US60/433,316 2002-12-13
US43623602P 2002-12-23 2002-12-23
US60/436,236 2002-12-23
US43791403P 2003-01-03 2003-01-03
US60/437,914 2003-01-03
US44082103P 2003-01-17 2003-01-17
US44082003P 2003-01-17 2003-01-17
US60/440,821 2003-01-17
US60/440,820 2003-01-17
US46370803P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US46370003P 2003-04-18 2003-04-18
US46371603P 2003-04-18 2003-04-18
US60/463,732 2003-04-18
US60/463,708 2003-04-18
US60/463,700 2003-04-18
US60/463,716 2003-04-18
US46723003P 2003-05-02 2003-05-02
US46720103P 2003-05-02 2003-05-02
US46720303P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US60/467,203 2003-05-02
US60/467,230 2003-05-02
US60/467,201 2003-05-02
US60/467,199 2003-05-02
US47133603P 2003-05-19 2003-05-19
US47130603P 2003-05-19 2003-05-19
US60/471,336 2003-05-19
US60/471,306 2003-05-19
US47242003P 2003-05-22 2003-05-22
US47243003P 2003-05-22 2003-05-22
US60/472,420 2003-05-22
US60/472,430 2003-05-22
US47662103P 2003-06-09 2003-06-09
US47664103P 2003-06-09 2003-06-09
US47663203P 2003-06-09 2003-06-09
US47660903P 2003-06-09 2003-06-09
US60/476,632 2003-06-09
US60/476,609 2003-06-09
US60/476,621 2003-06-09
US60/476,641 2003-06-09
US48532503P 2003-07-08 2003-07-08
US48522303P 2003-07-08 2003-07-08
US48521703P 2003-07-08 2003-07-08
US48535903P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US48521803P 2003-07-08 2003-07-08
US60/485,223 2003-07-08
US60/485,217 2003-07-08
US60/485,325 2003-07-08
US60/485,359 2003-07-08
US60/485,218 2003-07-08
US60/485,224 2003-07-08
US48644603P 2003-07-14 2003-07-14
US48648003P 2003-07-14 2003-07-14
US60/486,480 2003-07-14
US60/486,446 2003-07-14
US48696003P 2003-07-15 2003-07-15
US48689103P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US60/486,960 2003-07-15
US49337003P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US49357303P 2003-08-08 2003-08-08
US60/493,370 2003-08-08
US60/493,577 2003-08-08
US60/493,573 2003-08-08
US60/493,341 2003-08-08

Publications (2)

Publication Number Publication Date
WO2004038003A2 WO2004038003A2 (fr) 2004-05-06
WO2004038003A3 true WO2004038003A3 (fr) 2004-12-09

Family

ID=32180903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/033947 WO2004038003A2 (fr) 2002-10-25 2003-10-24 Polypeptides humains codes par des polynucleotides et methodes d'utilisation

Country Status (2)

Country Link
AU (1) AU2003298606A1 (fr)
WO (1) WO2004038003A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825328B1 (en) 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
WO2005012526A1 (fr) 2003-08-04 2005-02-10 The Hospital For Sick Children Gene de la maladie de lafora
US7910722B2 (en) 2007-07-05 2011-03-22 Florida State University Research Foundation RNAi therapeutic for treatment of hepatitis C infection
GB201011819D0 (en) * 2010-07-14 2010-09-01 King S College London Neurodegenerative disorders
TWI821905B (zh) * 2016-05-11 2023-11-11 美商安美基公司 使用麩醯胺合成酶基因內互補載體直接選擇表現高水準異質蛋白的細胞
CN109142729B (zh) * 2018-06-14 2021-04-23 郑州大学第一附属医院 一种肺癌标志物抗-hmgb3自身抗体及其应用
BR112021006941A2 (pt) 2018-10-19 2021-08-31 The Francis Crick Institute Limited Antígenos de câncer inovadores e métodos

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075967A1 (fr) * 2000-03-30 2001-10-11 Lam Research Corporation Decapage in situ et ex situ pour sti dotee d'une application de collier oxyde

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075967A1 (fr) * 2000-03-30 2001-10-11 Lam Research Corporation Decapage in situ et ex situ pour sti dotee d'une application de collier oxyde

Also Published As

Publication number Publication date
AU2003298606A8 (en) 2004-05-13
WO2004038003A2 (fr) 2004-05-06
AU2003298606A1 (en) 2004-05-13

Similar Documents

Publication Publication Date Title
WO2004035732A3 (fr) Polypeptides humains codes par des polynucleotides et procedes d'utilisation de ces polypeptides
WO2004020595A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004000997A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
WO2004093804A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation associees
WO2002055705A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2002068649A3 (fr) Proteines et acides nucleiques les codant
WO2003080856A3 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2002081518A3 (fr) Proteines, polynucleotides les codant et leurs procedes d'utilisation
WO2001090155A3 (fr) Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002068652A3 (fr) Proteines et acides nucleiques codant ces proteines
WO2002081510A3 (fr) Proteines, polynucleotides codant pour celles-ci et methodes d'utilisation
WO2004038003A3 (fr) Polypeptides humains codes par des polynucleotides et methodes d'utilisation
WO2004020591A3 (fr) Methodes d'utilisation de nouveaux polypeptides humains codes par des polynucleotides
WO2002055704A3 (fr) Proteines, polynucleotides codant pour elles et procedes d'utilisation correspondants
WO2003029423A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
WO2005085280A3 (fr) Clones d'adnc humains comportant des polynucleotides et leurs procedes d'utilisation
WO2004039952A3 (fr) Procedes d'utilisation de polypeptides humains codes par des polynucleotides
WO2003022998A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes
WO2003078572A3 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et procedes d'utilisation
WO2003031571A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et methodes d'utilisation afferentes
WO2004046310A3 (fr) Nouveaux polypeptides de souris codes par des polynucleotides et leurs procedes d'utilisation
WO2003040329A3 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
WO2004031354A3 (fr) Antigenes associes au sarcome humain
WO2004094598A3 (fr) Procedes d'utilisation pour de nouveaux polypeptides humains codes par des polynucleotides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载